Article PDF
Avoid common mistakes on your manuscript.
References
Link MG, Yan G-X, Kowey PR. Evaluation of toxicity for heart failure therapeutics: studying effects on the QT interval. Circ Heart Fail. 2010;3:547–555.
Turner JR, Karnad DR, Kothari S. Cardiovascular Safety in Drug Development and Therapeutic Use: New Methodologies and Evolving Regulatory Landscapes. Gewerbestrasse, Switzerland: Springer International Publishing; 2017.
Vandetanib Prescribing Information. http://www.caprelsa.com/. Accessed August 7, 2018.
Turner JR. Cardiac safety education: A Call to Action. AMPS-QT, 3rd Quarter 2017 issue. http://www.amps-llc.com/uploads/2017-12-7/AMPS-QT_3q17.pdf. Accessed August 7, 2018.
Turner JR. Integrated cardiovascular safety: multifaceted considerations in drug development and therapeutic use. Expert Opin Drug Saf. 2017;16:481–492.
Turner JR, Rodriquez I, Mantovani E, et al; on behalf of the Cardiac Safety Research Consortium. Drug-induced proarrhythmia and torsade de pointes: a primer for students and practitioners of medicine and pharmacy. J Clinical Pharmacol. 2018;58:997–1012.
Vlachos K, Georgopoulos S, Efremidis M, Sideris A, Letsas KP. An update on risk factors for drug-induced arrhythmias. Expert Rev Clin Pharmacol. 2016;9:117–127.
Vandael E, Vandenberk B, Vandenberg J, Willems R, Foulon V. Risk factors for QTc-prolongation: systematic review of the evidence. Int J Clin Pharm. 2017;39:16–25.
Heemskerk CPM, Pereboom M, van Stralen K, et al. Risk factors for QTc interval prolongation. Eur J Clin Pharmacol. 2018;74:183–191.
Beach SR, Celano CM, Sugrue AM, et al. QT Prolongation, torsades de pointes, and psychotropic medications: a 5-year update. Psychosomatics. 2018;59:105–122.
Dhanani TC, Mantovani EH, Turner JR. Clinical pharmacists’ opportunities to reduce inappropriate prescription of QT-prolonging medications: calls to action. Int J Pharm Pract. 2017;25:176–179.
Rights and permissions
About this article
Cite this article
Turner, J.R. Proposed Proarrhythmic Cardiac Safety Education in Medical, Pharmacy, and Nursing Schools: An Interprofessional Model. Ther Innov Regul Sci 52, 529–530 (2018). https://doi.org/10.1177/2168479018797715
Published:
Issue Date:
DOI: https://doi.org/10.1177/2168479018797715